Levetiracetam Levera Injection 100mg

Get a Price/Quote

MOQ : 10 Pieces

Levetiracetam Levera Injection 100mg Specification

Salt Composition
Levetiracetam 100 mg/5 ml

Pacakaging (Quantity Per Box)
1 vial per box

Dosage Form
Injection

Origin of Medicine
India

Life Span
Check package for expiry date

Packaging Type
Vial

Brand Name
Levera

Indication
For the adjunctive therapy of partial onset seizures

Drug Type
Allopathic

Ingredients
Levetiracetam

Physical Form
Injection

Function
Anti-epileptic, controls seizures

Recommended For
Patients with epilepsy/seizures

Dosage
100 mg (as per prescription)

Dosage Guidelines
For intravenous infusion only. Dosage as directed by physician.

Suitable For
Adults and children (as per physicians guidance)

Quantity
5 ml vial

Storage Instructions
Store in a cool, dry place. Protect from light.

Market Approval
Available internationally (Canada, Europe, UK, USA, Australia)

Route of Administration
Intravenous

Usage
Rx only

Caution
Use under medical supervision

Prescription Required
Yes

Color
Clear solution

Storage Temperature
Below 25C

Levetiracetam Levera Injection 100mg About

Experience an elite, new release in epilepsy management with Levetiracetam Levera Injection 100mg. Crafted for those seeking enviable reliability, this famed anti-epileptic solution ensures unparalleled control over partial onset seizures as an adjunctive therapy. Approved in leading global markets including Canada, Europe, the UK, USA, and Australia, Levera offers clear value for both adult and pediatric patients under prescription. Supplied in a clear 5 ml vial, its purity, simple storage below 25C, and allopathic formulation cater to modern healthcare standards. Use strictly under medical supervision.

Versatile Application Areas and Commercial Benefits

Levetiracetam Levera Injection 100mg is specifically designed for intravenous administration in both adults and children, as guided by a physician. Its primary application area is healthcare institutions, catering to patients suffering from epilepsy or seizures. Benefiting hospitals, specialty clinics, and neurology centers, this solution is ideal for swift, controlled intervention in seizure management. The product's compatibility with a variety of clinical environments ensures adaptability and exceptional patient care in both public and private healthcare sectors.

Premium Handling, Drop-off, and Market Coverage

Levetiracetam Levera Injection 100mg delivers premium reliability from manufacturer to user. Shipped via secure and trusted drop-off services through approved FOB ports in India, swift arrival guarantees product integrity. Samples are available under a well-defined policy to institutions seeking assessment prior to bulk purchase. Main domestic markets include leading Indian metro cities, ensuring rapid distribution and stock availability for healthcare providers seeking an internationally recognized, high-standard medication.

FAQ's of Levetiracetam Levera Injection 100mg:

Q: How is Levetiracetam Levera Injection 100mg administered?

A: Levetiracetam Levera Injection 100mg is administered intravenously, typically by healthcare professionals in a clinical setting. The dosage and administration rate are determined by the treating physician.

Q: What are the main benefits of using Levera Injection for seizures?

A: Levera Injection offers rapid, reliable control of partial onset seizures, making it an effective adjunctive anti-epileptic therapy. Its clear formulation and international approvals ensure high quality and safety standards.

Q: When should Levetiracetam Levera Injection be used?

A: The injection should be used when prescribed by a qualified physician for patients requiring adjunctive therapy for partial onset seizures. It is suitable for both adults and children under careful supervision.

Q: Where is Levetiracetam Levera Injection 100mg approved for use?

A: Levera Injection has received market approval for use in Canada, Europe, the UK, the USA, Australia, and India, ensuring its availability in premier healthcare systems worldwide.